Page last updated: 2024-08-21

dronabinol and Acanthamoeba Meningoencephalitis

dronabinol has been researched along with Acanthamoeba Meningoencephalitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bradley, SG; Cabral, G; Ferguson, T; Marciano-Cabral, F	1

Other Studies

1 other study(ies) available for dronabinol and Acanthamoeba Meningoencephalitis

Article	Year
Delta-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, exacerbates brain infection by Acanthamoeba. The Journal of eukaryotic microbiology, 2001, Volume: Suppl Topics: Acanthamoeba; Amebiasis; Animals; Antibodies, Protozoan; Brain Diseases; Central Nervous System Protozoal Infections; Cyclophosphamide; Disease Models, Animal; Dronabinol; Female; Humans; Immunocompetence; Immunocompromised Host; Immunosuppressive Agents; Mice	2001

Article

Year

Delta-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, exacerbates brain infection by Acanthamoeba.

The Journal of eukaryotic microbiology, 2001, Volume: Suppl

Topics: Acanthamoeba; Amebiasis; Animals; Antibodies, Protozoan; Brain Diseases; Central Nervous System Protozoal Infections; Cyclophosphamide; Disease Models, Animal; Dronabinol; Female; Humans; Immunocompetence; Immunocompromised Host; Immunosuppressive Agents; Mice

2001